Life Sciences & Biotechnology
Title: | NGS-based High-Throughput
Diagnostics |
Area: | Engineering Sciences, Life Sciences & Biotechnology, COVID-19 Technology |
Focus Area: | Diagnostics kit development for COVID-19 |
Company Transferred: | Syngene International Ltd |
Developing Agency: | Centre for Cellular and Molecular Biology
(CSIR-CCMB), Hyderabad |
Technology Readiness Index: | Technology development |
Website Link : | https://www.ccmb.res.in/ |
Brief Description
Description : | The technology allows using Next Generation Sequencing (NGS) for a high-throughput COVID-19 testing-of up to 10,000-50,000 samples in one go at each facility. The technology is now being tried at a pilot scale for the states of Telangana and Karnataka. |
Related Technologies